Extra Horizon Logo Colour Transparant

ams AG selects Extra Horizon to power innovative point-of-care cloud solution for its lab-quality, spectral sensor-enhanced lateral flow test solution to help fight covid-19 (sars-cov-2)

EXTRA HORIZON
Feb 02, 2021

News facts

  • ams and Extra Horizon team to fight the pandemic by creating a medical-cloud connected spectral sensor-based solution for Lateral Flow Test (LFT)
  • ams provides an easy-to-use, lab-free Covid-19 (SARS-CoV-2) antigen or antibody test read-out solution which provides highly reliable results in around 15 minutes at the point-of-care
ams AG Extra Horizon partnership
  • Extra Horizon provides it's world leading, high-performance, medical-grade cloud solution for almost instant results to your smartphone
  • The proven capabilities of Extra Horizon’s global platform ensures test results can be processed over a wide geographical reach securely, reliably, in real time – up to millions at a time –, all the while ensuring full compliance with local data processing regulations, including GDPR for handling sensitive data
  • A full production line for ams spectral sensor-based SARS-CoV-2 antibody digital rapid tests has already been inaugurated with Germany-based Senova

Premstaetten, Austria and Hasselt, Belgium, February 3, 2021


Today, ams (SIX: AMS), a leading worldwide supplier of high-performance sensor solutions, announces that it has chosen the high-performance cloud infrastructure developed by Extra Horizon to power a range of innovative point-of-care, spectral sensor-based solutions that harness the full power of digital health. Particularly in the context of the ongoing COVID-19 pandemic where fast and accurate testing is crucial to safeguarding public health, ams and Extra Horizon’s connected sensor solution and the highly accurate and efficient point-of-care tests it enables, together offer a unique response to a global problem.

An extra weapon in the fight against COVID-19

The COVID-19 pandemic has underlined the importance of highly accurate and secure rapid testing and instant data availability, particularly when that data is critical to developing and managing lockdown strategies. The combination of the ams spectral sensor and Extra Horizon’s connected solution pave the way for a range of digital point-of-care tests, including extremely fast and highly accurate lateral flow (immuno assay) tests. In fact, a full production line for SARS-CoV-2 antibody digital rapid tests has already been inaugurated as a result of the technology. Moreover, the proven capabilities of Extra Horizon’s global platform ensure a wide geographical reach. This means the results of those tests can be processed securely, reliably and in real time, up to millions at a time – all the while ensuring full compliance with local data processing regulations, including GDPR for handling sensitive data. 

Pierre Laboisse

Executive Vice President Global Sales and Marketing

ams AG

“Governments and authorities need to enable fast, reliable and effective testing with the results available through a fast, secure and GDPR-compliant medical-grade cloud solution. Extra Horizon offers best-in-class medical cloud solutions through their deeply proven expertise in medical cloud. The company’s professional expertise in developing customized solutions, leveraging an extensive backbone knowledge, makes it an ideal partner for this important undertaking. We hope that this solution will eliminate complicated logistics and clinical processes and streamline approaches to mass testing and effectively become an essential tool in the effort to help control the pandemic and resume the many economic and social activities that comprise what we call normal life.”

Driving the digital transition of IVD technologies

“Governments and authorities need to enable fast, reliable and effective testing with the results available through a fast, secure and GDPR-compliant medical-grade cloud solution. Extra Horizon offers best-in-class medical cloud solutions through their deeply proven expertise in medical cloud. The company’s professional expertise in developing customized solutions, leveraging an extensive backbone knowledge, makes it an ideal partner for this important undertaking. We hope that this solution will eliminate complicated logistics and clinical processes and streamline approaches to mass testing and effectively become an essential tool in the effort to help control the pandemic and resume the many economic and social activities that comprise what we call normal life.”

Lars Grieten

CEO

Extra Horizon

“This global partnership is a powerful demonstration of how state-of-the-art health tech sensors can be enhanced with digital infrastructure to deliver point-of-care testing solutions both in the professional and home environment. Rapid testing will become more relevant in our digitized future. And by enabling critical decisions to be taken faster, it is already providing much needed support for managing the COVID-19 crisis.”

An easy replicable formula

The software component of the point-of-care sensor solution is powered by Extra Horizon’s robust and fully compliant backend solution. The platform relieves the burden of regulatory compliance and reduces investment risk, providing companies with the technical framework and complementary services they need to build sophisticated medical applications with greater speed, flexibility, scalability, and reliability. 

About ams AG

ams is a global leader in the design and manufacture of advanced sensor solutions. Our mission is to shape the world with sensor solutions by providing a seamless interface between humans and technology. 


ams’ high-performance sensor solutions drive applications requiring small form factor, low power, highest sensitivity and multi-sensor integration. Products include sensor solutions, sensor ICs, interfaces and related software for consumer, communications, industrial, medical, and automotive markets. 


With headquarters in Austria, ams employs around 9,000 people globally and serves more than 8,000 customers worldwide. ams is listed on the SIX Swiss Exchange (ticker symbol: AMS). More information about ams can be found here.


ams is a registered trademark of ams AG. In addition many of our products and services are registered or filed trademarks of ams Group. All other company or product names mentioned herein may be trademarks or registered trademarks of their respective owners. Information provided in this press release is accurate at time of publication and is subject to change without advance notice.


RECENT POSTS

By Extra Horizon 26 Jan, 2024
We’re excited to introduce our latest tutorial for building a blood pressure monitoring app with Extra Horizon! Dive into the step-by-step guide, tailored for all skill levels, and discover hands-on experiences with our CLI and SDK. Plus, explore our Control Center enhancements, featuring bug fixes and usability improvements, ensuring an optimal user experience. Read on to explore the new features of SDK v8.0.0 and the revamped Schema Verification process via the CLI.
By Extra Horizon 28 Nov, 2023
We have some exciting things to share with you today! Join our SLCT Beta Program for IEC62304 compliant software development. Plus, check out our RQL 7.8.0 update that boasts some nice new improvements and bug fixes.
Show all ->

FREE EBOOKS

Building and releasing medical device software is hard, very hard. Here at Extra Horizon we have had
By Free ebook 11 Oct, 2022
Get a thorough yet simple guide to IEC 62304 in Extra Horizon's ebook. Unlock insights into software development for medical devices.
ISO 13485 Ebook Medical Device Development
By Free ebook 27 Apr, 2022
Learn the thirteen essential boxes to tick on the path to ISO 13485:2016 certification. Gain insights and guidance in Extra Horizon's ebook. Download now!

GOT QUESTIONS?

Get in touch, we're eager to answer your questions

Share by: